Essler M - Search Results

1

Dichotomous regulation of myosin phosphorylation and shape change by Rho-kinase and calcium in intact human platelets.

Bauer M, Retzer M, Wilde JI, Maschberger P, Essler M, Aepfelbacher M, Watson SP, Siess W. Bauer M, et al. Among authors: essler m. Blood. 1999 Sep 1;94(5):1665-72. Blood. 1999. PMID: 10477691 Free article.

2

Mildly oxidized low density lipoprotein induces contraction of human endothelial cells through activation of Rho/Rho kinase and inhibition of myosin light chain phosphatase.

Essler M, Retzer M, Bauer M, Heemskerk JW, Aepfelbacher M, Siess W. Essler M, et al. J Biol Chem. 1999 Oct 22;274(43):30361-4. doi: 10.1074/jbc.274.43.30361. J Biol Chem. 1999. PMID: 10521411 Free article.

3

Mildly oxidised low density lipoprotein induces platelet shape change via Rho-kinase-dependent phosphorylation of myosin light chain and moesin.

Retzer M, Siess W, Essler M. Retzer M, et al. Among authors: essler m. FEBS Lett. 2000 Jan 21;466(1):70-4. doi: 10.1016/s0014-5793(99)01762-7. FEBS Lett. 2000. PMID: 10648815 Free article.

4

Cyclic AMP blocks bacterial lipopolysaccharide-induced myosin light chain phosphorylation in endothelial cells through inhibition of Rho/Rho kinase signaling.

Essler M, Staddon JM, Weber PC, Aepfelbacher M. Essler M, et al. J Immunol. 2000 Jun 15;164(12):6543-9. doi: 10.4049/jimmunol.164.12.6543. J Immunol. 2000. PMID: 10843713

5

Lysophosphatidic acid-induced platelet shape change proceeds via Rho/Rho kinase-mediated myosin light-chain and moesin phosphorylation.

Retzer M, Essler M. Retzer M, et al. Among authors: essler m. Cell Signal. 2000 Oct;12(9-10):645-8. doi: 10.1016/s0898-6568(00)00108-x. Cell Signal. 2000. PMID: 11080616

6

Sphingosine 1-phosphate dynamically regulates myosin light chain phosphatase activity in human endothelial cells.

Essler M, Retzer M, Ilchmann H, Linder S, Weber PC. Essler M, et al. Cell Signal. 2002 Jul;14(7):607-13. doi: 10.1016/s0898-6568(02)00013-x. Cell Signal. 2002. PMID: 11955953

7

Cytotoxic necrotizing factor 1 of Escherichia coli stimulates Rho/Rho-kinase-dependent myosin light-chain phosphorylation without inactivating myosin light-chain phosphatase in endothelial cells.

Essler M, Linder S, Schell B, Hüfner K, Wiedemann A, Randhahn K, Staddon JM, Aepfelbacher M. Essler M, et al. Infect Immun. 2003 Sep;71(9):5188-93. doi: 10.1128/IAI.71.9.5188-5193.2003. Infect Immun. 2003. PMID: 12933863 Free PMC article.

8

Lysophosphatidic acid is the unique platelet-activating substance in human malignant ascites.

Sandmann G, Siess W, Essler M. Sandmann G, et al. Among authors: essler m. Eur J Med Res. 2003 Sep 29;8(9):397-404. Eur J Med Res. 2003. PMID: 14555295

9

Thrombin inactivates myosin light chain phosphatase via Rho and its target Rho kinase in human endothelial cells.

Essler M, Amano M, Kruse HJ, Kaibuchi K, Weber PC, Aepfelbacher M. Essler M, et al. J Biol Chem. 1998 Aug 21;273(34):21867-74. doi: 10.1074/jbc.273.34.21867. J Biol Chem. 1998. PMID: 9705325 Free article.

10

Pasteurella multocida toxin increases endothelial permeability via Rho kinase and myosin light chain phosphatase.

Essler M, Hermann K, Amano M, Kaibuchi K, Heesemann J, Weber PC, Aepfelbacher M. Essler M, et al. J Immunol. 1998 Nov 15;161(10):5640-6. J Immunol. 1998. PMID: 9820544

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

227 results

Search Page

Filters